Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testosterone may influence COVID-19 severity and outcomes.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Anabolic steroid users may face higher risk of severe COVID-19.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Androgens can both increase body hair and cause scalp hair loss.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.